𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Single crystal and powder diffraction characterization of three polymorphic forms of Acitretin

✍ Scribed by Luciana Malpezzi; Grato Angelo Magnone; Norberto Masciocchi; Angelo Sironi


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
578 KB
Volume
94
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Solid state characterization and crystal
✍ HΓ©ctor Novoa de Armas; Oswald M. Peeters; Norbert Blaton; Elke Van Gyseghem; Joh πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 393 KB

Ranitidine hydrochloride (RAN-HCl), a known anti-ulcer drug, is the product of reaction between HCl and ranitidine base (RAN-B). RAN-HCl has been extensively studied; however this is not the case of the RAN-B. The solid state characterization of RAN-B polymorphs has been carried out using different

Thermodynamic characterization of three
✍ Ricardo Picciochi; HermΓ­nio P. Diogo; Manuel E. Minas da Piedade πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 217 KB

Combustion calorimetry, solution calorimetry, and differential scanning calorimetry (DSC) were used to determine the standard (p β€’ = 0.1 MPa) molar enthalpies of formation of Forms I, II, and III piracetam at 298.15 K, namely, f H β€’ m (C 6 H 10 O 2 N 2 , cr I) = -520.6 Β± 1.6 kJβ€’mol -1 , f H β€’ m (C 6

Analysis of N-(4-hydroxyphenyl)retinamid
✍ F. A. Chrzanowski; B. J. Fegely; W. R. Sisco; M. P. Newton πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 317 KB

A quantitative X-ray diffraction method, with zinc oxide used as the internal standard, was developed for the analysis of polymorphic forms I and II of N-(4-hydroxyphenyl)retinamide. The standard curve relating peak height ratio to the percentage of form I was linear. The method was precise and accu

Structural determination of the stable a
✍ Gregory A. Stephenson; Cikui Liang πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 199 KB

Stratteratrade mark is the first FDA-approved nonstimulant medication for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children, adolescents, and adults. Two polymorphic forms and an amorphous form of the active pharmaceutical ingredient, atomoxetine HCl, were discovered durin